Neuroscience
Neurofibromatosis Type 1
100%
Pervasive Developmental Disorder
100%
Simvastatin
50%
Randomized Controlled Trial
25%
Attention Deficit Hyperactivity Disorder
18%
Statin
13%
Gamma-Aminobutyric Acid
12%
Mitogen-Activated Protein Kinase
8%
Arterial Spin Labeling
8%
Placebo
8%
Medicine and Dentistry
Neurofibromatosis Type I
75%
Pervasive Developmental Disorder
75%
Simvastatin
50%
Toddlers
35%
Statin
13%
Social Adaptation
12%
Gamma-Aminobutyric Acid
12%
Arterial Spin Labeling
8%
Placebo
8%
Mitogen-Activated Protein Kinase
8%
Prevalence
6%
Cohort Effect
6%
Pharmacology, Toxicology and Pharmaceutical Science
Statin (Protein)
62%
Neurofibromatosis Type 1
50%
Simvastatin
50%
4 Aminobutyric Acid
12%
Placebo
8%
Autism
8%